Pfizer Inc. (NYSE:PFE) is scheduled to release last fiscal quarter's results before the opening bell on January 31, 2012. Let's take a look at how Pfizer has done in recent quarters. Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company was founded in 1849 and is headquartered in New York, New York.
52 Week High: $22.17
52 Week Low: $16.63
Book Value: $11.71
Float Short: 0.83%
On average, 15 analysts are expecting a drop of $-0.15 in earnings per share compared to last quarter's results of $0.62. Wall Street is expecting $0.47 per share, based on earnings estimates. Analyst estimates range between $0.43 and $0.50 per share.
The current trailing twelve months P/E ratio is 9.5. The forward P/E ratio is 9.47. From a month ago, the stock has decreased in price -0.51%, and moving in price 17.40% from one year ago. When comparing to the S&P 500, the year to date difference is -4.26%.
The chart for Pfizer looks great. All the moving averages are moving higher, the last price is well above all the averages, and the 90 day moving average just busted through the 200 day moving average. For trend followers, Pfizer is a buy on dips typs of trade. The very low earnings multiple makes this big pharma nearly bulletproof going into earnings. The almost zero interest by shorts to take a bearish position is screaming through silence this is not a short candidate.
Revenue year-over-year has increased to $67.81 billion for 2010 vs. $50.01 billion for 2009. The bottom line has falling earnings year-over-year of $8.26 billion for 2010 vs. $8.64 billion for 2009.The company's earnings before interest and taxes are falling with an EBIT year-over-year of $9.42 billion for 2010 vs. $10.83 billion for 2009.
Thank you for reading my article. Please also feel free to share your thoughts and comments.
I use a proprietary blend of technical analysis, financial crowd behavior, and fundamentals in my short-term trades, and while not totally the same in longer swing trades to investments, the concepts used are similar. You may want to use this article as a starting point of your own research with your financial planner. I use Seeking Alpha, Edgar Online, and Yahoo Finance for most of my data. I use the "confirmed" symbols from earnings.com that I believe to be of the most interest